AN ACT relating to the Kentucky all-payer claims database.
SB 340 establishes a Kentucky all-payer claims database within the Cabinet for Health and Family Services, administered through the Office of Data Analytics. The database is intended to collect and analyze health care claims data from a broad range of payers, including Medicaid, Medicare, CHIP, insurers, self-insured plans, workers’ compensation carriers, pharmacy benefit managers, and certain government health plans. The stated purposes are to support population health initiatives, state health planning, research on cost/quality/access, evaluation of health programs, and quality improvement efforts.
The bill creates a restricted fund to support the database, authorizes the executive director to seek grants, contract with third parties, enter data-sharing agreements, and promulgate regulations governing reporting, access, privacy, and security. It also establishes an advisory council with representatives from hospitals, physicians, pharmacists, dentists, primary care, insurers, employers, workers’ compensation, consumers, academia, and state agencies to advise on implementation and ongoing operation. The bill requires annual reporting to the Governor and legislature on the database’s status, finances, performance, and recommended changes.
SB 340 would add a new statutory framework in KRS Chapter 194A for statewide health claims data collection and analysis, and it amends related provisions in KRS 194A.030, KRS 194A.101, and KRS 304.2-100 to assign responsibilities to the Office of Data Analytics and the Insurance Commissioner. It also creates enforcement authority and civil penalties of up to $1,000 per day for noncompliant health payers, with penalties deposited into the database fund. The bill expressly preserves certificate-of-need law and includes privacy, confidentiality, and federal-law compliance provisions, while requiring federal authorization if needed to avoid loss of federal funds or to comply with federal requirements.
The bill appears generally policy-oriented and administrative rather than overtly partisan, with an emphasis on improving health care transparency, cost analysis, and planning. The structure of the bill suggests support for a data-driven health policy tool, and the inclusion of multiple stakeholder groups on the advisory council indicates an effort to build broad institutional buy-in. No committee transcript or recorded votes were provided, so there is no direct evidence of floor or committee sentiment beyond the bill’s detailed, implementation-focused design.
The main points of potential contention are likely to be data privacy, the scope of mandatory reporting, and the burden on payers and self-insured plans. The bill requires submission of claims data without individual consent where permitted by federal law, prohibits reidentification and commercial use, and allows the executive director to require unique patient identifiers, which may raise privacy concerns. Health insurers, employers, and other payers may also object to reporting costs, audits, and penalties, while providers and consumer advocates may differ on how much data should be made available and how it should be used. The bill’s broad reach across public and private payers, including government plans and Medicare/Medicaid data, is likely the most significant area for debate.